High-volume cancer centers with greater NACT use show reduced 90-day surgical mortality and improved 60-month survival for advanced-stage ovarian cancer patients. The study analyzed data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback